We are live on ! Find out more
BEAT icon

Heartbeam

0.5500 USD
+0.0111
2.06%
At close Updated Oct 30, 4:00 PM EDT
Pre-market
After hours
0.5600
+0.0100
1.82%
1 day
2.06%
5 days
40.31%
1 month
50.03%
3 months
6.34%
6 months
-35.9%
Year to date
-77.37%
1 year
-65.84%
5 years
-88.27%
10 years
-88.27%
 

About: HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.

Employees: 16

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 12.5%
Neutral 87.5%
Negative 0%
Neutral
Business Wire
2 days ago
HeartBeam to Present Results of ALIGN-ACS Study for Heart Attack Assessment at TCT 2026 on November 1, 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Present Results of ALIGN-ACS Study for Heart Attack Assessment at TCT 2026 on November 1, 2026.
HeartBeam to Present Results of ALIGN-ACS Study for Heart Attack Assessment at TCT 2026 on November 1, 2026
Neutral
Business Wire
9 days ago
HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology
SANTA CLARA, Calif.--(BUSINESS WIRE)--HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology.
HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology
Neutral
Business Wire
15 days ago
HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome.
HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients
Positive
Benzinga
25 days ago
HeartBeam Secures FDA Designation for At-Home Heart Attack Detection System
Medical technology provider HeartBeam, Inc. (NASDAQ:BEAT) received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its at-home cardiac assessment tool.
HeartBeam Secures FDA Designation for At-Home Heart Attack Detection System
Neutral
Business Wire
25 days ago
HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment.
HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
Neutral
Business Wire
1 month ago
HeartBeam, Inc. Letter to Shareholders
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. Letter to Shareholders.
HeartBeam, Inc. Letter to Shareholders
Neutral
Seeking Alpha
2 months ago
HeartBeam, Inc. (BEAT) Q2 2026 Earnings Call Transcript
HeartBeam, Inc. (BEAT) Q2 2026 Earnings Call Transcript
HeartBeam, Inc. (BEAT) Q2 2026 Earnings Call Transcript
Neutral
Business Wire
2 months ago
HeartBeam Reports Second Quarter 2026 Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Second Quarter 2026 Results.
HeartBeam Reports Second Quarter 2026 Results
Neutral
Business Wire
3 months ago
HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time.
HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time
Positive
Zacks Investment Research
3 months ago
Healthcare IT is the Next AI Growth Story: 3 Stocks to Buy Now
Healthcare IT is emerging as AI's next growth story as providers adopt AI to cut costs & improve care. Here we present three stocks that are likely to benefit.
Healthcare IT is the Next AI Growth Story: 3 Stocks to Buy Now
Price charts implemented using Lightweight Charts™